246 related articles for article (PubMed ID: 16177277)
1. Predicting drug efficacy for cognitive deficits in schizophrenia.
Hagan JJ; Jones DN
Schizophr Bull; 2005 Oct; 31(4):830-53. PubMed ID: 16177277
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
3. Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia.
Floresco SB; Geyer MA; Gold LH; Grace AA
Schizophr Bull; 2005 Oct; 31(4):888-94. PubMed ID: 16079387
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cognitive dysfunction in schizophrenia.
Peuskens J; Demily C; Thibaut F
Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199
[TBL] [Abstract][Full Text] [Related]
5. The role of the α7 nicotinic receptor in cognitive processing of persons with schizophrenia.
AhnAllen CG
Curr Opin Psychiatry; 2012 Mar; 25(2):103-8. PubMed ID: 22262029
[TBL] [Abstract][Full Text] [Related]
6. On the trail of a cognitive enhancer for the treatment of schizophrenia.
Stip E; Chouinard S; Boulay LJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228
[TBL] [Abstract][Full Text] [Related]
7. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.
Barak S; Weiner I
Pharmacol Biochem Behav; 2011 Aug; 99(2):164-89. PubMed ID: 21420999
[TBL] [Abstract][Full Text] [Related]
8. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
Brown JW; Rueter LE; Zhang M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
[TBL] [Abstract][Full Text] [Related]
9. Executive function in schizophrenia: what impact do antipsychotics have?
O'Grada C; Dinan T
Hum Psychopharmacol; 2007 Aug; 22(6):397-406. PubMed ID: 17579928
[TBL] [Abstract][Full Text] [Related]
10. [Learning potential and cognitive remediation in schizophrenia].
Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
[TBL] [Abstract][Full Text] [Related]
11. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
Abdul-Monim Z; Reynolds GP; Neill JC
Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
[TBL] [Abstract][Full Text] [Related]
12. Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
Sharma T
Br J Psychiatry Suppl; 1999; (38):44-51. PubMed ID: 10884899
[No Abstract] [Full Text] [Related]
13. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
[TBL] [Abstract][Full Text] [Related]
14. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
15. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
16. [Cognitive deficits in schizophrenia and other psychotic disorders].
Fagerlund B; Glenthøj BY
Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728
[TBL] [Abstract][Full Text] [Related]
17. Methods for treating cognitive deficits in schizophrenia.
Bowie CR; Jaga K
Expert Rev Neurother; 2007 Mar; 7(3):281-7. PubMed ID: 17341176
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic treatment in schizophrenia: the role of computerized neuropsychological assessment.
Kertzman S; Reznik I; Grinspan H; Weizman A; Kotler M
Isr J Psychiatry Relat Sci; 2008; 45(2):114-20. PubMed ID: 18982837
[TBL] [Abstract][Full Text] [Related]
19. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
[TBL] [Abstract][Full Text] [Related]
20. [Memory disorders in schizophrenia].
Danion JM; Peretti S; Gras-Vincendon A; Singer L
Encephale; 1992; 18 Spec No 2():315-28. PubMed ID: 1363948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
